全球化学发光免疫分析仪市场规模、份额、成长分析、按产品、按应用、按最终用户 - 产业预测 2024-2031

2022年，全球化学发光免疫分析仪市场规模为54.1亿美元，预计将从2023年的58.2亿美元成长到2031年的103.7亿美元，在预测期内（2024-2031年）复合年增长率为7.5 %。

近年来，慢性病和传染病病例的增加导致全球化学发光市场的成长。儘管如此，由于它们在识别与各种医学疾病相关的这些标记物方面具有很高的敏感性和特异性，因此它们在诊断实验室中发挥着至关重要的作用。使用化学发光免疫分析仪，可以轻鬆识别或追踪癌症、心臟病和传染病等疾病。因此，在高度重视医疗保健，特别是疾病的早期发现的现代社会，对准确、快速的诊断仪器的持续需求。由于全球医疗保健成本上升以及早期诊断意识的提高，该市场正在发展。除了政府之外，私人医疗机构也正在采用先进的诊断技术，以提高病患的治疗效果。

目录

执行摘要

• 市场概况
• 命运之轮

研究方法论

• 资讯采购
• 二手和主要资料来源
• 市场规模估计
• 市场假设与限制

母公司市场分析

• 市场概况
• 市场规模
• 市场动态
  • 司机
  • 机会
  • 限制
  • 挑战

主要市场洞察

• 技术分析
• 定价分析
• 供应链分析
• 价值链分析
• 市场生态系统
• 智慧财产权分析
• 贸易分析
• 启动分析
• 原料分析
• 创新矩阵
• 管道产品分析
• 总体经济指标
• 顶级投资分析
• 成功的关键因素
• 竞争程度

市场动态与展望

• 市场动态
  • 司机
  • 机会
  • 限制
  • 挑战
• 监管环境
• 波特分析
• 对未来颠覆的特别见解

全球化学发光免疫分析仪市场（按产品）

• 市场概况
• 全自动化学发光免疫分析仪及半自动化学发光免疫分析仪

全球化学发光免疫分析仪市场（按应用）

• 市场概况
• 传染病检测
• 内分泌系统测试
• 心臟标记测试
• 肿瘤学测试
• 自体免疫疾病检测
• 过敏测试
• 其他的

全球化学发光免疫分析仪市场（按最终用户）

• 市场概况
• 医院
• 诊断实验室
• 研究机构
• 和即时检测

全球化学发光免疫分析仪市场规模（按地区）

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 拉丁美洲其他地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • MEA 的其余部分

竞争格局

• 前 5 名玩家比较
• 2023 年关键参与者的市场定位
• 主要市场参与者所采取的策略
• 最佳制胜策略
• 近期市集活动
• 主要公司市占率 (%), 2023

主要公司简介

• Roche Diagnostics
• Abbott
• Siemens Healthcare
• Ortho Clinical Diagnostics
• Beckman Coulter
• Danaher (Beckman Coulter Life Sciences)
• Johnson & Johnson (Ortho-Clinical Diagnostics)
• DiaSorin
• Luminex Corporation
• Tosoh Bioscience
• Snibe Diagnostics
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Sysmex Corporation
• Hytest Ltd.
• Bio-Rad Laboratories, Inc.
• PerkinElmer, Inc.
• ARCHITECT Diagnostics, Inc.
• Euroimmun Medizinische Labordiagnostika AG
• Mesan Pharma
• Abbott Point-of-Care Inc.

Global Chemiluminescence Immunoassay Analyzers Market size was valued at USD 5.41 billion in 2022 and is poised to grow from USD 5.82 billion in 2023 to USD 10.37 billion by 2031, growing at a CAGR of 7.5% during the forecast period (2024-2031).

The rise in chronic and infectious disease cases has led to a growth in the global chemiluminescence market in recent years. Nonetheless, because of their great sensitivity and specificity in identifying these markers associated with various medical disorders, they play a crucial role in diagnostic laboratories. Using chemiluminescence immunoassay analyzers, ailments like cancer, heart problems, and infectious infections can be easily identified or tracked. Because of this, there is a continuing need for accurate and quick diagnostic instruments in the modern society, which places a strong emphasis on health care, particularly the early detection of disease. The market is developing as a result of rising healthcare costs globally and rising awareness of early diagnosis. Private healthcare institutions are embracing advanced diagnostic technology, in addition to governments, toward enhancing patients' results.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Chemiluminescence Immunoassay Analyzers Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the Market size includes the following details: The key players in the Market were identified through secondary research, and their Market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top Market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Chemiluminescence Immunoassay Analyzers Market Segmental Analysis

The global chemiluminescence immunoassay analyzers market is segmented into four major segments i.e. by product type, application, end user, and region. Based on type, it is divided into fully automated chemiluminescence immunoassay analyzers and semi-automated chemiluminescence immunoassay analyzers. Based on application, it is bifurcated as infectious disease testing, endocrine system testing, cardiac marker testing, oncology testing, autoimmune disease testing, allergy testing, and others. Based on end users it is segregated into hospitals, diagnostic laboratories, research institutes, and point-of-care testing. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.

Drivers of the Global Chemiluminescence Immunoassay Analyzers Market

More advanced tools are needed for accurate and timely diagnosis due to the increased prevalence of infectious and chronic diseases. Chemiluminescence immunoassay analyzers, which are frequently used in many diagnostics laboratories, are among those well-known brands. The global emphasis on illness prevention and early detection also contributes to the rise in demand for these analyzers. This is true since technical advancements are crucial, and regular upgrades raise the bar, improve accuracy, and so forth.

Restraints in the Global Chemiluminescence Immunoassay Analyzers Market

The substantial upfront and ongoing costs of purchasing and maintaining these advanced diagnostic devices are one of the primary market barriers. Smaller healthcare facilities and labs may find it more difficult to implement this cutting-edge equipment due to the significant initial cost. Furthermore, there may be a learning curve for medical practitioners due to the intricacy of these analyzers and their data interpretation procedures, which could slow down and reduce the accuracy of diagnoses. The market's growth may also be hampered by regional regulatory obstacles and compliance problems, which call for adherence to various standards and approval procedures.

Market Trends of the Global Chemiluminescence Immunoassay Analyzers Market

These analyzers' automated artificial intelligence (AI) integration speeds up diagnostic interpretations and laboratory turnaround times. It also makes administering tests easier, reduces the time needed to get results, and improves accuracy. Furthermore, there is a growing interest in expanding the applications of these devices to include hormone diagnostic research, microbial infection detection, and cancer diagnosis. In order to meet the expanding demand for PoC testing and remote diagnostics, manufacturers are also concentrating on creating more user-friendly and portable analyzers.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Chemiluminescence Immunoassay Analyzers Market by Product

• Market Overview
• Fully Automated Chemiluminescence Immunoassay Analyzers and Semi-Automated Chemiluminescence Immunoassay Analyzers

Global Chemiluminescence Immunoassay Analyzers Market by Application

• Market Overview
• Infectious Disease Testing
• Endocrine System Testing
• Cardiac Marker Testing
• Oncology Testing
• Autoimmune Disease Testing
• Allergy Testing
• and Others

Global Chemiluminescence Immunoassay Analyzers Market by End User

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Research Institutes
• and Point-of-Care Testing

Global Chemiluminescence Immunoassay Analyzers Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (Beckman Coulter Life Sciences)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (Ortho-Clinical Diagnostics)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tosoh Bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Snibe Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hytest Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARCHITECT Diagnostics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Euroimmun Medizinische Labordiagnostika AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mesan Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Point-of-Care Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments